Background
Background Velo-cardio-facial Velo-cardio-facial syndrome (VCFS) is associated with syndrome (VCFS) is associated with interstitial deletions of chromosome interstitial deletions of chromosome 22q11. About 30% of patients withVCFS 22q11. About 30% of patients withVCFS have psychosis, and the rate of these have psychosis, and the rate of these deletions in schizophrenia has been deletions in schizophrenia has been reported to be about1%.Even higher reported to be about1%.Even higher rates of VCFS deletions have been rates of VCFS deletions have been reported for childhood-onset reported for childhood-onset schizophrenia. schizophrenia.
Aims Aims To testthe hypothesis thatthere is
To test the hypothesis that there is an increased rate of VCFS among patients an increased rate of VCFS among patients with early-onset psychosis (age at onset with early-onset psychosis (age at onset 5 518 years). We screened192 early-onset 18 years). We screened192 early-onset patients and 329 patients with adult-onset patients and 329 patients with adult-onset schizophrenia. schizophrenia.
Method Method We genotyped the patients
We genotyped the patients and 444 healthy controls for hemizygosity and 444 healthy controls for hemizygosity of five microsatellite markers and one of five microsatellite markers and one single nucleotide polymorphism that map single nucleotide polymorphism that map to the 22q11-deleted region. to the 22q11-deleted region.
Results

Results One patient had aVCFS
One patient had aVCFS deletion, confirmed with semideletion, confirmed with semiquantitative polymerase chain reaction. quantitative polymerase chain reaction. None of the controls showed a pattern of None of the controls showed a pattern of genotypes consistent with hemizygosity. genotypes consistent with hemizygosity.
Conclusions
Conclusions VCFS may be less VCFS may be less frequent among patients with psychosis frequent among patients with psychosis than previously suggested; this rate is not than previously suggested; this rate is not increased among early-onset patients. increased among early-onset patients. Velo-cardio-facial syndrome (VCFS) is a Velo-cardio-facial syndrome (VCFS) is a genetic disorder associated with characterisgenetic disorder associated with characteristic dysmorphology, cleft palate, cardiac tic dysmorphology, cleft palate, cardiac anomalies and major psychiatric disorders, anomalies and major psychiatric disorders, including schizophrenia (Shprintzen including schizophrenia (Shprintzen et al et al, , 1978; Murphy 1978; Murphy et al et al, 1999) . The frequencies , 1999). The frequencies of the disorder have been reported to be 1/ of the disorder have been reported to be 1/ 4000 (Wilson 4000 (Wilson et al et al, 1994) and 1/9700 live , 1994) and 1/9700 live births (du Montcel births (du Montcel et al et al, 1996) , but both , 1996), but both of these frequencies were only minimum of these frequencies were only minimum estimates. The disorder is associated with inestimates. The disorder is associated with interstitial deletions of chromosome 22q11; terstitial deletions of chromosome 22q11; 87% of cases share a 3 Mb deletion, 8% 87% of cases share a 3 Mb deletion, 8% have a smaller nested 1.5 Mb deletion, 4% have a smaller nested 1.5 Mb deletion, 4% have one of two other nested deletions and have one of two other nested deletions and the remainder have unique deletions (Shaikh the remainder have unique deletions (Shaikh et al et al, 2000) (Fig. 1) . It has been proposed , 2000) ( Fig. 1) . It has been proposed that deletions in this region are facilitated that deletions in this region are facilitated by the presence of low copy repeats by the presence of low copy repeats (LCR22) at the boundaries of the various (LCR22) at the boundaries of the various deletions (Carlson deletions (Carlson et al et al, 1997) . Most cases , 1997). Most cases occur sporadically in the population, indioccur sporadically in the population, indicating that the 22q11 region is highly prone cating that the 22q11 region is highly prone to rearrangement. to rearrangement.
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Background Background
Several studies of individuals with VCFS Several studies of individuals with VCFS have reported an increased incidence of psyhave reported an increased incidence of psychosis, particularly schizophrenia (Shprintchosis, particularly schizophrenia (Shprintzen zen et al et al, 1992; Karayiorgou , 1992; Karayiorgou et al et al, 1995; , 1995; Papolos Papolos et al et al, 1996; Gothelf , 1996; Gothelf et al et al, 1997; , 1997; Bassett Bassett et al et al, 1998; Murphy , 1998; Murphy et al et al, 1999; , 1999; Usiskin Usiskin et al et al, 1999) . The rate of VCFS in , 1999). The rate of VCFS in patients with schizophrenia is reported to patients with schizophrenia is reported to be 0.33-2% (Chow be 0.33-2% (Chow et al et al, 1997; Karayior-, 1997; Karayiorgou gou et al et al, 1997; Arinami , 1997; Arinami et al et al, 2001 Arinami et al et al, ), com-, 2001 , compared with the frequency in the general pared with the frequency in the general population of only population of only * *0.025% (Wilson 0.025% (Wilson et et al al, 1994) . When individuals with schizo-, 1994) . When individuals with schizophrenia have been selected for the presence phrenia have been selected for the presence of two or more clinical features consistent of two or more clinical features consistent with VCFS (palatal, cardiac, facial or other with VCFS (palatal, cardiac, facial or other congenital anomalies, and/or learning difficongenital anomalies, and/or learning difficulties), 22q11 deletions have been identiculties), 22q11 deletions have been identified in 20-59% of cases (Gothelf fied in 20-59% of cases (Gothelf et al et al, , 1997; Bassett 1997; Bassett et al et al, 1998) . , 1998).
Recently, it has been suggested that Recently, it has been suggested that VCFS might be especially common in indi-VCFS might be especially common in individuals with psychosis of early onset. Papoviduals with psychosis of early onset. Papolos los et al et al (1996) reported that bipolar illness (1996) reported that bipolar illness associated with VCFS usually has a childassociated with VCFS usually has a childhood onset, whereas Usiskin hood onset, whereas Usiskin et al et al (1999 Usiskin et al et al ( ) (1999 reported that 3/47 (6.4%) patients with a reported that 3/47 (6.4%) patients with a very-early-onset diagnosis of schizophrenia very-early-onset diagnosis of schizophrenia ( (5 513 years) had VCFS deletions.
13 years) had VCFS deletions.
Aim Aim
To test the hypothesis that there is an To test the hypothesis that there is an increased rate of VCFS among patients with increased rate of VCFS among patients with early-onset psychosis, we screened 192 early-onset psychosis, we screened 192 patients whose first psychotic episode had patients whose first psychotic episode had occurred before their 18th birthday occurred before their 18th birthday (referred to as juvenile-onset cases) for (referred to as juvenile-onset cases) for 22q11 deletions. We postulated that more 22q11 deletions. We postulated that more than 1% of patients would have such delethan 1% of patients would have such deletions. We also screened 329 patients with tions. We also screened 329 patients with schizophrenia whose age at onset had been schizophrenia whose age at onset had been after their 18th birthday, to estimate the after their 18th birthday, to estimate the frequency of VCFS deletions in a more frequency of VCFS deletions in a more typical sample of cases. typical sample of cases.
METHOD METHOD Subjects Subjects
All patients were recruited as part of our All patients were recruited as part of our ongoing genetic association studies. The ongoing genetic association studies. The juvenile-onset subjects were recruited in juvenile-onset subjects were recruited in the UK and Bulgaria and had an age at the UK and Bulgaria and had an age at onset before their 18th birthday. Age-atonset before their 18th birthday. Age-atonset of illness was defined as the age of onset of illness was defined as the age of first occurrence of delusions, hallucinations first occurrence of delusions, hallucinations or mania. In order to determine age at onset or mania. In order to determine age at onset reliably, we only included information that reliably, we only included information that was present in concurrent hospital or outwas present in concurrent hospital or outpatient records. The Bulgarian sample conpatient records. The remaining subjects were 329 unThe remaining subjects were 329 unrelated UK patients with schizophrenia related UK patients with schizophrenia who did not satisfy our criteria for juvenile who did not satisfy our criteria for juvenile onset, either because their age at onset was onset, either because their age at onset was clearly more than 18 years or because there clearly more than 18 years or because there was insufficient information available to was insufficient information available to define onset precisely. Of these, 244 were define onset precisely. Of these, 244 were male and 85 were female. Subjects with male and 85 were female. Subjects with an IQ an IQ 5 570 were excluded. In Bulgaria, 70 were excluded. In Bulgaria, patients were recruited by their own patients were recruited by their own psychiatrists from both in-and out-patient psychiatrists from both in-and out-patient settings in the capital Sofia and two major settings in the capital Sofia and two major towns and their surrounding districts in towns and their surrounding districts in the south and south-west of the country. the south and south-west of the country. In the UK, patients were recruited via In the UK, patients were recruited via psychiatrists from in-patient and outpsychiatrists from in-patient and outpatient services from a number of centres patient services from a number of centres in Wales and England. in Wales and England.
All patients were interviewed with an All patients were interviewed with an abbreviated version of the Schedules for abbreviated version of the Schedules for Clinical Assessment in Neuropsychiatry Clinical Assessment in Neuropsychiatry (SCAN; Wing (SCAN; Wing et al et al, 1990 ) and a best-, 1990) and a bestestimate consensus diagnosis was reached estimate consensus diagnosis was reached on the basis of the interview and psychiatric on the basis of the interview and psychiatric hospital notes by two experienced rehospital notes by two experienced researchers. The DSM-IV (American Psysearchers. The DSM-IV (American Psychiatric Association, 1994) diagnostic chiatric Association, 1994) diagnostic criteria were used in the study. The teams criteria were used in the study. The teams in Bulgaria and the UK used the same clinin Bulgaria and the UK used the same clinical instruments. The consensus diagnoses ical instruments. The consensus diagnoses in Bulgaria were made in each case by in Bulgaria were made in each case by G.K. and I.N. The UK sample was collected G.K. and I.N. The UK sample was collected over a period of several years by a number over a period of several years by a number of different fieldworkers. A consensus diagof different fieldworkers. A consensus diagnosis had to be reached by two of them for nosis had to be reached by two of them for a patient to be included in the study. All a patient to be included in the study. All patients were interviewed when they were patients were interviewed when they were adults. adults.
We also genotyped a sample of 444
We also genotyped a sample of 444 healthy blood donors who had been healthy blood donors who had been broadly matched for gender and age with broadly matched for gender and age with the patients from the general and juvenile the patients from the general and juvenile samples from the UK population. The samples from the UK population. The blood donors were recruited from the UK blood donors were recruited from the UK blood transfusion service in Cardiff, Wales. blood transfusion service in Cardiff, Wales. All patients and controls signed an All patients and controls signed an informed consent form for participation in informed consent form for participation in genetic association studies. genetic association studies.
Genotyping Genotyping
We screened for the presence of deletions We screened for the presence of deletions by genotyping five microsatellite markers by genotyping five microsatellite markers and one single nucleotide polymorphism and one single nucleotide polymorphism in the deleted VCFS region (Fig. 1) . in the deleted VCFS region (Fig. 1) . Individuals who have a deletion are Individuals who have a deletion are expected to have only one allele for each expected to have only one allele for each of these markers because they have only of these markers because they have only one copy of the chromosome 22 for this reone copy of the chromosome 22 for this region. The chances of an individual having gion. The chances of an individual having only one allele of any one marker but havonly one allele of any one marker but having two copies of that marker (i.e. being ing two copies of that marker (i.e. being homozygous for that marker) depend on homozygous for that marker) depend on the allele frequencies and number of alleles the allele frequencies and number of alleles of the marker. The heterozygosity (the freof the marker. The heterozygosity (the frequency of observing individuals with two quency of observing individuals with two different alleles) of the markers that we different alleles) of the markers that we chose ranged from chose ranged from * *30% for PCQAP to 30% for PCQAP to 89% for D22S264. The probability that 89% for D22S264. The probability that an individual is homozygous for each of an individual is homozygous for each of the six markers in the absence of deletions the six markers in the absence of deletions is low ( is low (* *0.1%), therefore we expected 0.1%), therefore we expected that this method would allow us to end that this method would allow us to end up with only a small number of individuals up with only a small number of individuals who were potential candidates to have who were potential candidates to have deletions. We intended to confirm the deletions. We intended to confirm the presence of a deletion by fluorescence presence of a deletion by fluorescence in situ in situ hybridisation (FISH) if we had hybridisation (FISH) if we had available cell lines from that individual, or available cell lines from that individual, or by semi-quantitative polymerase chain by semi-quantitative polymerase chain reaction (PCR; see below). Our screening reaction (PCR; see below). Our screening method is much more cost-effective method is much more cost-effective compared with performing FISH on all compared with performing FISH on all the samples. the samples.
For the juvenile cases we used three For the juvenile cases we used three known microsatellite markers (D22S264, known microsatellite markers (D22S264, D22S941, D22S944), one CA repeat that D22S941, D22S944), one CA repeat that we identified from the genomic sequence we identified from the genomic sequence of the clone AC000068.2 (indicated as of the clone AC000068.2 (indicated as AC0068.2 in Fig. 1 ) and one CAG repeat AC0068.2 in Fig. 1 ) and one CAG repeat within the gene PCQAP (described by De within the gene PCQAP (described by De Luca Luca et al et al, 2003) . This ensured that even , 2003). This ensured that even some of the smaller, less common deletions some of the smaller, less common deletions were covered with a sufficient number of were covered with a sufficient number of polymorphic markers. All five markers are polymorphic markers. All five markers are in the typically deleted region (3 Mb) and, in the typically deleted region (3 Mb) and, with the exception of PCQAP, are also with the exception of PCQAP, are also within the less common region (1.5 Mb) within the less common region (1.5 Mb) deleted in 8% of the patients with VCFS deleted in 8% of the patients with VCFS (Fig. 1) . The single nucleotide poly- (Fig. 1) . The single nucleotide polymorphism that we used is a well-known morphism that we used is a well-known marker within the catecholmarker within the catechol-O O-methyltrans--methyltransferase (COMT) gene (Val158Met) that has ferase (COMT) gene (Val158Met) that has been reported in numerous studies in the been reported in numerous studies in the 4 1 0 4 1 0 For the patients with schizophrenia For the patients with schizophrenia having an age at onset of more than having an age at onset of more than 18 years we used five microsatellite 18 years we used five microsatellite markers markers (D22S1638, D22S941, D22S944, (D22S1638, D22S941, D22S944, D22S264, D22S264, D22S311) and the Val158Met D22S311) and the Val158Met single nucleotide polymorphism at COMT. single nucleotide polymorphism at COMT. All the microsatellites are within the All the microsatellites are within the common (3 Mb) deleted region. common (3 Mb) deleted region.
The microsatellites were amplified The microsatellites were amplified using standard PCRs with forward primers using standard PCRs with forward primers 5 5 0 -labelled with fluorescent dyes (FAM, -labelled with fluorescent dyes (FAM, HEX or TET). The fragments were loaded HEX or TET). The fragments were loaded together and resolved on an AB1373 together and resolved on an AB1373 automated sequencer. automated sequencer.
Confirmation of VCFS deletion Confirmation of VCFS deletion
To confirm the presence of VCFS deletion To confirm the presence of VCFS deletion we used semi-quantitative PCR. For this we used semi-quantitative PCR. For this assay we simultaneously amplified two assay we simultaneously amplified two fragments in the same reaction. One fragments in the same reaction. One fragment was chosen within exon 5 of fragment was chosen within exon 5 of COMT (which should be deleted in VCFS COMT (which should be deleted in VCFS cases) and the other fragment was chosen cases) and the other fragment was chosen from exon 11 of the ABCG1 gene on from exon 11 of the ABCG1 gene on chromosome 21. Both genes have been chromosome 21. Both genes have been screened extensively in the past for genetic screened extensively in the past for genetic variants: the ABCG1 gene by us (Kirov variants: the ABCG1 gene by us (Kirov et et al al, 2001 ) and the COMT gene by a number , 2001) and the COMT gene by a number of teams. This ensured that there would be of teams. This ensured that there would be no common polymorphisms within these no common polymorphisms within these fragments that can interfere with the fragments that can interfere with the reaction. Primer sequences for the COMT reaction. Primer sequences for the COMT fragment were: fragment were:
forward: CTGTTCCAGGTCACCCTTGT forward: CTGTTCCAGGTCACCCTTGT reverse: CAGGTACCGGTCCTTCCAGT reverse: CAGGTACCGGTCCTTCCAGT For ABCG1 we used the following primers: For ABCG1 we used the following primers:
forward: TCATTGGCCTGCTGTACTTG forward: TCATTGGCCTGCTGTACTTG reverse: CAGCGGTCTGTCACTCACAT reverse: CAGCGGTCTGTCACTCACAT The forward primer of each pair was 5 The forward primer of each pair was 5 0 --labelled with a fluorescent dye (FAM). labelled with a fluorescent dye (FAM). The fragment from COMT amplified a proThe fragment from COMT amplified a product 120 bp in size, whereas the ABCG1 duct 120 bp in size, whereas the ABCG1 amplified a product of 141 bp. All four amplified a product of 141 bp. All four primers were added to the same PCR primers were added to the same PCR reaction, thus ensuring identical conditions reaction, thus ensuring identical conditions for the amplification of both fragments. We for the amplification of both fragments. We optimised the reaction by reducing the optimised the reaction by reducing the number of cycles so that it was terminated number of cycles so that it was terminated during the exponential phase of the PCR, during the exponential phase of the PCR, during which the amount of PCR product during which the amount of PCR product is dependent upon the starting number of is dependent upon the starting number of DNA template molecules. The PCR DNA template molecules. The PCR products were quantitated on an ABI373 products were quantitated on an ABI373 automated sequencer. If a person has a automated sequencer. If a person has a single copy of COMT, then the ratio of single copy of COMT, then the ratio of the amounts of the PCR products representthe amounts of the PCR products representing COMT and ABCG1 is ing COMT and ABCG1 is * *50% that of 50% that of the ratio obtained from an individual with the ratio obtained from an individual with two copies of COMT (Fig. 2) . two copies of COMT (Fig. 2) .
RESULTS RESULTS
To confirm that our approach detects VCFS To confirm that our approach detects VCFS deletions, we genotyped a sample of deletions, we genotyped a sample of 45 patients with known VCFS deletions 45 patients with known VCFS deletions previously diagnosed using FISH (the previously diagnosed using FISH (the sample is fully described by Murphy sample is fully described by Murphy et al et al, 1999). We used five microsatellites , 1999). We used five microsatellites (D22S944, D22S1638, D22S941, D22S264, (D22S944, D22S1638, D22S941, D22S264, D22S311) and the COMT Val158Met D22S311) and the COMT Val158Met single nucleotide polymorphism. Our single nucleotide polymorphism. Our approach correctly identified all 45 known approach correctly identified all 45 known cases of VCFS deletions by showing that cases of VCFS deletions by showing that they had only one allele for each marker they had only one allele for each marker within the deleted region. within the deleted region.
In the test sample, only one individual In the test sample, only one individual (a patient with schizophrenia) gave a (a patient with schizophrenia) gave a pattern of homozygosity for all markers pattern of homozygosity for all markers tested. This effectively excludes the tested. This effectively excludes the presence of deletions in the rest of the presence of deletions in the rest of the population. The homozygous individual population. The homozygous individual had been genotyped also for a number of had been genotyped also for a number of single nucleotide polymorphisms in three single nucleotide polymorphisms in three genes from the VCFS region as part of our genes from the VCFS region as part of our ongoing genetic research projects. We ongoing genetic research projects. We observed that he was homozygous for every observed that he was homozygous for every single nucleotide polymorphism genotyped single nucleotide polymorphism genotyped in the COMT, ARVCF and TBX1 genes in the COMT, ARVCF and TBX1 genes (a total of 20 single nucleotide poly-(a total of 20 single nucleotide polymorphisms), thus adding further evidence morphisms), thus adding further evidence that he had a VCFS deletion. We did not that he had a VCFS deletion. We did not have a cell line for this individual and were have a cell line for this individual and were unable to confirm the deletion by FISH. We unable to confirm the deletion by FISH. We therefore performed the semi-quantitative therefore performed the semi-quantitative PCR described above. To provide positive PCR described above. To provide positive and negative controls for the assay, we also and negative controls for the assay, we also genotyped known individuals with VCFS genotyped known individuals with VCFS and those without VCFS, respectively. The and those without VCFS, respectively. The overlaid traces of one control, one known overlaid traces of one control, one known VCFS case and the suspected VCFS case VCFS case and the suspected VCFS case are shown in Fig. 2 . This experiment are shown in Fig. 2 . This experiment confirmed that the individual had a VCFS confirmed that the individual had a VCFS deletion because his trace was similar to deletion because his trace was similar to that of the known VCFS case and about that of the known VCFS case and about half the size of the COMT fragment of half the size of the COMT fragment of the non-deleted case. the non-deleted case.
DISCUSSION DISCUSSION
Prevalence of VCFS in patients Prevalence of VCFS in patients with schizophrenia with schizophrenia
The frequency of 22q11 deletions is estiThe frequency of 22q11 deletions is estimated to be at least 1:4000 in the general mated to be at least 1:4000 in the general population and approximately 30% of population and approximately 30% of people with this deletion develop symptoms people with this deletion develop symptoms of psychosis, especially schizophrenia of psychosis, especially schizophrenia (Pulver (Pulver et al et al, 1994; Murphy , 1994; Murphy et al et al, 1999) . , 1999). Karayiorgou Karayiorgou et al et al (1997) reported that 3/ (1997) reported that 3/ 207 randomly selected patients with schizo-207 randomly selected patients with schizophrenia had a 22q11 deletion and on retrophrenia had a 22q11 deletion and on retrospective assessment had facial features of spective assessment had facial features of VCFS (this report includes the 100 patients VCFS (this report includes the 100 patients reported earlier by this group (Karayiorgou reported earlier by this group (Karayiorgou et al et al, 1995) ). Chow , 1995)). Chow et al et al (1997 Chow et al et al ( ) reported (1997 reported that 2/100 randomly selected Chinese that 2/100 randomly selected Chinese patients with schizophrenia had 22q11.2 patients with schizophrenia had 22q11.2 deletions. Arinami deletions. Arinami et al et al (2001) identified (2001) identified one patient with a 22q11.2 deletion among one patient with a 22q11.2 deletion among 300 randomly selected patients with schizo-300 randomly selected patients with schizophrenia. In the present study, we did not phrenia. In the present study, we did not identify a single patient with a 22q11 identify a single patient with a 22q11 deletion among 192 patients with earlydeletion among 192 patients with earlyonset psychosis and therefore the present onset psychosis and therefore the present study does not provide support for the study does not provide support for the hypothesis that there is a higher incidence hypothesis that there is a higher incidence of 22q11 deletions among patients with of 22q11 deletions among patients with early-onset psychosis. We identified only early-onset psychosis. We identified only one such case among an additional sample one such case among an additional sample of 329 schizophrenia cases with a nonof 329 schizophrenia cases with a nonjuvenile age at onset of illness, which is a juvenile age at onset of illness, which is a lower rate than in the previous reports. lower rate than in the previous reports.
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Fig. 2 Fig. 2 Overlaid images of the products of the COMT (left) and ABCG1 (right) fragments of three individuals.
Overlaid images of the products of the COMT (left) and ABCG1 (right) fragments of three individuals.
The lower two traces (almost identical) of the COMT fragment are from one known velo-cardio-facial The lower two traces (almost identical) of the COMT fragment are from one known velo-cardio-facial syndrome (VCFS) case and the patient with schizophrenia that we tested.The size of the peaks is syndrome (VCFS) case and the patient with schizophrenia that we tested.The size of the peaks is * *50% smaller 50% smaller than the peak of the control (top trace). than the peak of the control (top trace).
The patient with VCFS deletion that we The patient with VCFS deletion that we identified did not have a recognised low IQ identified did not have a recognised low IQ but had left school with no qualifications. but had left school with no qualifications. He did not have children. According to He did not have children. According to his own account, he developed signs of illhis own account, he developed signs of illness at around the age of 17 years, when ness at around the age of 17 years, when he thought that his father was the Devil he thought that his father was the Devil (there was no hospital documentation to (there was no hospital documentation to support this, so he did not satisfy our strict support this, so he did not satisfy our strict criteria for inclusion in the juvenile psychocriteria for inclusion in the juvenile psychosis sample). His first hospitalisation was at sis sample). His first hospitalisation was at the age of 21 years. Over the years he had the age of 21 years. Over the years he had exhibited auditory and olfactory halluexhibited auditory and olfactory hallucinations, thought withdrawal, bizarre cinations, thought withdrawal, bizarre delusions, paranoid ideas and suicidal delusions, paranoid ideas and suicidal ideation. ideation.
Statistical consideration Statistical consideration
If the frequency of 22q11 deletions was 2% If the frequency of 22q11 deletions was 2% in juvenile-onset samples ascertained in juvenile-onset samples ascertained according to our criteria then we would according to our criteria then we would have had 98% power to detect at least have had 98% power to detect at least one observation of a deletion. If the true one observation of a deletion. If the true rate is 1%, the corresponding power was rate is 1%, the corresponding power was 85%. Our data suggest that if people with 85%. Our data suggest that if people with psychosis, including juvenile-onset cases, psychosis, including juvenile-onset cases, have an increased risk of 22q11 deletions have an increased risk of 22q11 deletions it is only a modest increase. On combining it is only a modest increase. On combining our data with the three previous studies our data with the three previous studies that estimated the frequency of VCFS in that estimated the frequency of VCFS in subjects ascertained for schizophrenia withsubjects ascertained for schizophrenia without major bias towards co-ascertaining out major bias towards co-ascertaining subjects with VCFS, there are seven obsersubjects with VCFS, there are seven observations of 22q11 deletions out of 1077 vations of 22q11 deletions out of 1077 individuals with schizophrenia, which is individuals with schizophrenia, which is a prevalence of a prevalence of * *0.65% (we exclude 0.65% (we exclude individuals with bipolar disorder in our individuals with bipolar disorder in our sample from the overall figure) . sample from the overall figure) .
If the prevalence of VCFS is 1:4000 in If the prevalence of VCFS is 1:4000 in the general population and 24% of these the general population and 24% of these people develop schizophrenia (Murphy people develop schizophrenia (Murphy et et al al, 1999) , then 1:16 666 of the general , 1999), then 1:16 666 of the general population should have both schizophrenia population should have both schizophrenia and VCFS. Assuming that the prevalence of and VCFS. Assuming that the prevalence of schizophrenia is 1% in the general popuschizophrenia is 1% in the general population, we would expect that 1:166 or lation, we would expect that 1:166 or 0.6% of randomly ascertained subjects 0.6% of randomly ascertained subjects with schizophrenia would have VCFS. The with schizophrenia would have VCFS. The frequently quoted figure of 1/4000 for frequently quoted figure of 1/4000 for VCFS in the general population is only an VCFS in the general population is only an approximation based on the rate of congeapproximation based on the rate of congenital heart defects (Wilson nital heart defects (Wilson et al et al, 1994) . , 1994). The only other large study (du Montcel The only other large study (du Montcel et et al al, 1996) reported a frequency of 1:9700 , 1996) reported a frequency of 1:9700 based on symptomatic cases from a Birth based on symptomatic cases from a Birth Defects Registry in France. Both studies Defects Registry in France. Both studies stressed that the rate of milder cases is stressed that the rate of milder cases is likely to be higher but the precise incidence likely to be higher but the precise incidence is not known, therefore our estimate that an is not known, therefore our estimate that an unselected sample of 0.6% of patients with unselected sample of 0.6% of patients with schizophrenia should also have VCFS can schizophrenia should also have VCFS can be only an approximation. However, it be only an approximation. However, it concurs well with the figure of 0.65% that concurs well with the figure of 0.65% that represents the combined world literature. represents the combined world literature. Further large-scale screens are required on Further large-scale screens are required on samples ascertained using epidemiological samples ascertained using epidemiological principles to obtain a precise estimate principles to obtain a precise estimate of the risk for this deletion in typical of the risk for this deletion in typical schizophrenia. schizophrenia.
Age at onset and IQ Age at onset and IQ One possible characteristic of our sample One possible characteristic of our sample that may have reduced the prevalence of dethat may have reduced the prevalence of deletions is that individuals with an IQ of letions is that individuals with an IQ of 5 570 were excluded. In the study of 70 were excluded. In the study of Arinami Arinami et al et al (2001) , the patient with (2001), the patient with schizophrenia and VCFS deletion had an schizophrenia and VCFS deletion had an IQ of 61. In the study of Karayiorgou IQ of 61. In the study of Karayiorgou et et al al (1997) , two patients with schizophrenia (1997), two patients with schizophrenia had a history of learning problems as had a history of learning problems as children. One of the two patients found children. One of the two patients found by Chow by Chow et al et al (1997) also had 'mental (1997) also had 'mental retardation'. Thus, a stricter interpretation retardation'. Thus, a stricter interpretation of our data is that a VCFS deletion is an unof our data is that a VCFS deletion is an uncommon cause for schizophrenia in patients common cause for schizophrenia in patients with a normal IQ. It is also important with a normal IQ. It is also important to note that all three individuals with to note that all three individuals with childhood-onset schizophrenia who were childhood-onset schizophrenia who were found to have VCFS in the study of Usiskin found to have VCFS in the study of Usiskin et al et al (1999) developed signs of psychosis (1999) developed signs of psychosis before their 13th birthday. Only eight of before their 13th birthday. Only eight of our patients had an onset this young our patients had an onset this young (Table 1) . It is therefore possible that the (Table 1) . It is therefore possible that the prevalence of 22q11 deletions is higher in prevalence of 22q11 deletions is higher in cases with very early onset, although cases with very early onset, although further work is needed in this unusual further work is needed in this unusual & group of cases. The patient that we identigroup of cases. The patient that we identified with VCFS had an illness onset at the fied with VCFS had an illness onset at the age of 17 years, but, even if we were to clasage of 17 years, but, even if we were to classify this patient as having a juvenile-onset sify this patient as having a juvenile-onset psychosis, the rate of VCFS among this psychosis, the rate of VCFS among this population is still lower than previously population is still lower than previously proposed. proposed.
Possible sources of bias Possible sources of bias
It is not known whether publication bias It is not known whether publication bias has influenced the previous estimates of has influenced the previous estimates of VCFS rates in patients with schizophrenia VCFS rates in patients with schizophrenia but it is more likely, in principle, that a but it is more likely, in principle, that a small study that detected at least one case small study that detected at least one case of VCFS will be published than a small of VCFS will be published than a small study that did not. This bias will act to instudy that did not. This bias will act to inflate the reported prevalence of VCFS in flate the reported prevalence of VCFS in the population with schizophrenia. On the the population with schizophrenia. On the other hand, our genetic study might be other hand, our genetic study might be biased against finding VCFS cases because biased against finding VCFS cases because we did not include patients with known we did not include patients with known low IQ, as discussed above. Another factor low IQ, as discussed above. Another factor that will reduce the observed prevalence of that will reduce the observed prevalence of VCFS is the increased mortality in VCFS is the increased mortality in these patients, due largely to congenital these patients, due largely to congenital heart disease. This would have been even heart disease. This would have been even greater 30 or 40 years ago, when many greater 30 or 40 years ago, when many potential current individuals with VCFS potential current individuals with VCFS would have been born, so that they would would have been born, so that they would be less likely to reach the average age of be less likely to reach the average age of ascertainment. ascertainment.
Criteria for screening for VCFS Criteria for screening for VCFS
Our data indicate that screening for VCFS Our data indicate that screening for VCFS is not justified in the general population is not justified in the general population of patients with psychosis, even in those of patients with psychosis, even in those with an early onset, at least when the first with an early onset, at least when the first episode of psychosis occurs after the age episode of psychosis occurs after the age of 13 years. The main criteria for screening of 13 years. The main criteria for screening in psychosis remain the presence of cleft lip in psychosis remain the presence of cleft lip and/or palate, characteristic dysmorphand/or palate, characteristic dysmorphology, learning disability, congenital heart ology, learning disability, congenital heart disease or hypocalcaemia (Murphy & disease or hypocalcaemia (Murphy & Owen, 1996; Gothelf Owen, 1996; Gothelf et al et al, 1997; Bassett , 1997; Bassett et al et al, 1998 Bassett et al et al, ). , 1998 
